Summary : Novo Nordisk said it had invested 15 years of continuous research to make the oral formulation of semaglutide into a…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
Tag:
anti-diabetic
-
-
IndiaTrade Marks
REMOGLIFLOZIN: INDIA IS THE FIRST COUNTRY TO GET ACCESS TO AN INNOVATIVE TYPE-2 DIABETES DRUG
by adminby adminRemogliflozin was discovered and developed by Japanese firm Kissei Pharmaceutical Co and subsequently developed by GlaxoSmithKline Plc and BHV Pharma, a…